|Grant Affiliation:||Letvin: rAdenoviral & rMycobacterial Vector Immunogens|
|Strategy:||Vector vaccines (viral or bacterial)|
|Study Type:||Pre-Clinical NHP|
|Study Start Date:||2009-10-20|
|Study Made Public:||2012-04-10|
Pilot study to assess immunogenicity of 1st generation recombinant Mycobacterial (rMyco) vaccine vectors
CAVD 294 is a non-human primate study comparing different doses and routes in BCG/Ad5 prime/boost regimens. A follow up boost study (CAVD 267) was performed.
Sign in to see full information about this study and to download study data.